State of the art for motor function assessment tools in spinal muscular atrophy (SMA)

Arch Pediatr. 2020 Dec;27(7S):7S40-7S44. doi: 10.1016/S0929-693X(20)30276-1.

Abstract

Spinal muscular atrophy (SMA) is a progressive disease characterized by a degeneration of the spinal cord motor neurons. Many clinical trials - planned, in progress, or completed - have chosen motor function as the primary or secondary outcome because motor function assessment tools appeared to be more reliable than quantitative muscle testing in monitoring the course of the disease. Reliable, valid, and responsive outcome measures are needed to be able to capture the effectiveness of the therapeutic approach during clinical trials. Medical staff involved in neuromuscular diseases is faced with increasing pressure regarding the complex issue of choosing the right outcome measure for the objectives they have to assess. This paper provides a narrative literature review of available and validated motor function assessment tools in SMA population based on SMA subtypes, age and ambulant status. © 2020 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.

Keywords: Assessment tools; Motor function scales; Outcome measures; Spinal muscular atrophy.

Publication types

  • Review

MeSH terms

  • Disease Progression
  • Humans
  • Psychomotor Performance*
  • Reproducibility of Results
  • Spinal Muscular Atrophies of Childhood / diagnosis*
  • Spinal Muscular Atrophies of Childhood / physiopathology
  • Spinal Muscular Atrophies of Childhood / therapy
  • Treatment Outcome